Answers are grounded in this paper and cite their sources.
Background Rheumatic diseases are persistent conditions often linked to chronic pain, functional impairments, and heightened psychological distress, all of which adversely impact patients’ mental health. Having an accurate evaluation of a patient’s distress tolerance is crucial. Therefore, the present research aimed to assess the validity and reliability of the Revised Chinese Distress Tolerance Scale (DTS-13) in patients with rheumatic diseases. Methods A total of 210 patients with rheumatic diseases completed the DTS-13, Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), and Type D personality scale-14 (DS-14). Reliability was examined using Cronbach’s α, McDonald’s Omega ( ω ), split-half reliability, and test-retest. Validity was assessed by Confirmatory Factor Analysis (CFA), Bayesian analysis, measurement invariance, Item Response Theory (IRT), convergent validity, discriminant validity, and incremental validity. Group differences were tested using Kruskal-Wallis and Mann-Whitney, and correlations were assessed using Spearman’s rho. Results The DTS-13 demonstrated strong internal consistency, with Cronbach’s α = 0.947, McDonald’s omega ( ω ) = 0.947, and a split-half coefficient of 0.841. Test-retest reliability was also moderate (Cronbach’s α = 0.857 and McDonald ’s Omega ( ω ) = 0.858). The internal consistency reliabilities of the four subscales ranged from 0.820 to 0.888, while their test-retest reliability coefficients ranged from 0.534 to 0.706. CFA and Bayesian analysis supported a four-factor model with a satisfactory model fit ( χ 2/df = 1.998, RMSEA = 0.069, Comparative Fit Index (CFI) = 0.973, Tucker-Lewis Index = 0.962, Standardized Root Mean Square Residual (SRMR) = 0.052, Posterior Predictive P-Value (PPP) = 0.173, Potential Scale Reduction (PSR) = 1.037). Multi-group CFA showed measurement invariance across both sex and diagnosis groups. IRT indicated high discriminative power across all items (α range: 1.13–2.36). Composite Reliability (CR) values ranged from 0.826 to 0.892, and Average Variance Extracted (AVE) ranged from 0.567 to 0.735. The criterion-related correlations showed significant negative associations between the DTS-13, PHQ-9, GAD-7, and negative affect, which were −0.581, −0.590, and −0.464, respectively. Discriminant validity was approved, as the √AVE (0.762) and Heterotrait-Monotrait Ratio of Correlations (HTMT) coefficients were 0.642–0.690. Hierarchical regression showed incremental, accounting for an additional 11% and 10% of the variance in anxiety and depression, respectively. Conclusion This study provides new evidence supporting the validity and reliability of the DTS-13 as a good scale for evaluating distress tolerance (DT) in rheumatic disease patients. This research significantly contributes by offering a tool to assess patients’ ability to detect and tolerate negative psychological conditions, supporting the development of early psychological interventions for reducing the emotional distress linked to chronic pain. Therefore, it is recommended to incorporate this scale into clinical protocols to improve mental care offered to rheumatic disease patients.
No takes yet. Share an insight, caveat, or question.
Sheikh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: